Raymond James & Associates Avid Bioservices, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 10,100 shares of CDMO stock, worth $125,442. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,100
Previous 10,100
-0.0%
Holding current value
$125,442
Previous $72,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CDMO
# of Institutions
187Shares Held
69.3MCall Options Held
89.9KPut Options Held
118K-
Black Rock Inc. New York, NY5.11MShares$63.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.19MShares$52 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.85MShares$47.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.82MShares$47.4 Million0.12% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.8MShares$47.2 Million4.48% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $772M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...